Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
Pharmacological Reports : PR|August 24, 2022
Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominanceRobert Flisiak, Dorota Zarębska-Michaluk, Magdalena Rogalska, et al.Gut|March 19, 2026
Molecular and cellular consequences of tumour-autonomous IL-6 signalling in intrahepatic cholangiocarcinomaVirag Gehl, Colm J O'Rourke, Martin Cornillet, et al.Viruses|January 21, 2023
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World DatabaseRobert Flisiak, Piotr Rzymski, Dorota Zarębska-Michaluk, et al.Journal of Clinical Medicine|September 9, 2023
Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 VariantRobert Flisiak, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, et al.Advances in Medical Sciences|February 9, 2023
Elevated levels of soluble glycoprotein V - The plasma marker of platelet activation by thrombin in patients with early stage primary biliary cholangitis (PBC)Pawel Rogalski, Dagmara Bogdanowska-Charkiewicz, Magdalena Rogalska-Plonska, et al.Journal of Clinical Medicine|September 13, 2025
Differences in the Clinical Course of COVID-19 in Patients Hospitalized in the 2023/2024 and 2024/2025 SeasonsRobert Flisiak, Dorota Zarębska-Michaluk, Michał Brzdęk, et al.Viruses|October 26, 2024
Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer StudyKarol Żmudka, Jerzy Jaroszewicz, Dorota Zarębska-Michaluk, et al.Plos One|December 25, 2015
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World SettingSteffen B Wiegand, Benjamin Heidrich, Simone Susser, et al.Journal of Clinical Medicine|December 23, 2022
The Course of COVID-19 in Patients with Systemic Autoimmune Rheumatic DiseasesMarta Rorat, Dorota Zarębska-Michaluk, Justyna Kowalska, et al.Cancers|August 7, 2021
Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free TherapyRobert Flisiak, Dorota Zarębska-Michaluk, Ewa Janczewska, et al.Pageof 8